ATF3 and breast cancer: Liu et al. found that ATF3 regulated BC cell resistance to tamoxifen through an N6-adenosine-based epigenetic transcriptomic mechanism and suggested that ATF3 may be a candidate therapeutic target to overcome drug resistance in cancer cell48.